Skip to content
2000
image of Causal Relationships Between Modifiable Risk Factors and Gastroesophageal Reflux Disease: A Two-Sample Mendelian Randomization Study

Abstract

Introduction

Gastroesophageal reflux disease (GERD) is a prevalent digestive disorder, yet the causal roles of modifiable risk factors remain unclear. This study aims to investigate the causal relationships between 28 modifiable risk factors (including obesity traits, mental health disorders, sleep traits, metabolic comorbidities, and serum parameters) and GERD using two-sample Mendelian randomization (MR). Gastroesophageal reflux disease (GERD). Our findings aim to inform targeted prevention and treatment strategies for GERD.

Methods

This study obtained data from extensive genome-wide association studies (GWAS). Pooled data associated with gastroesophageal reflux associations were obtained from the 23andMe Research team’s research, which included a total of 129,080 cases of gastroesophageal reflux and 473,524 controls of European ancestry. We conducted a univariable Mendelian randomization (MR) analysis to ascertain whether genetic evidence of exposure demonstrated a statistically significant association with the risk of GERD. Subsequently, a multivariable MR analysis was carried out to estimate the independent effects of the exposures on GERD.

Results

Univariable MR analysis utilizing extensive GWAS data suggested that genetic factors such as BMI, Waist circumference, Arm fat mass (left and right), Leg fat mass (left and right), Attention Deficit and Hyperactivity Disorder (ADHD), Major Depressive Disorder (MDD), Schizophrenia, Negative emotions (including nervousness, anxiety, tension, or depression), Insomnia, Sleep apnea syndrome, Sleep duration, and Snoring, as well as Total cholesterol levels and Apolipoprotein B levels, are associated with the development of GERD. Multivariate Mendelian randomization of BMI and Negative emotion as correction factors showed that Waist circumference, Arm fat mass (left and right), Leg fat mass (left and right), ADHD, Insomnia, Sleep apnea syndrome, and Snoring were associated with an increased risk of GERD (< 0.05). Conversely, longer sleep duration was associated with a reduced risk of GERD (< 0.05).

Discussion

This MR study reveals novel causal mechanisms in GERD pathogenesis: (1) Peripheral adiposity (arm/leg fat mass) exerts independent effects beyond central obesity, indicating site-specific fat distribution significance; (2) ADHD emerges as a distinct psychiatric risk factor independent of mental disorders; (3) Sleep apnea operates through BMI-independent pathways. Collectively, these findings redefine GERD pathophysiology, highlighting fat depot specificity and brain-gut interactions as critical mechanistic drivers.

Conclusion

Overall, our findings suggest that multiple risk factors are associated with the risk of GERD. These results provide a theoretical basis for controlling body weight and plasticity, improving sleep habits, and preventing and timely seeking medical attention to reduce the occurrence of psychiatric disorders, which will be important strategies to prevent and alleviate GERD.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cmc/10.2174/0109298673372983250710031732
2025-08-01
2025-09-14

  • From This Site

    /content/journals/cmc/10.2174/0109298673372983250710031732
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Fass R. Boeckxstaens G.E. El-Serag H. Rosen R. Sifrim D. Vaezi M.F. Gastro-oesophageal reflux disease. Nat. Rev. Dis. Primers 2021 7 1 55 10.1038/s41572‑021‑00287‑w 34326345
    [Google Scholar]
  2. Sweis R. Fox M. The global burden of gastro-oesophageal reflux disease: more than just heartburn and regurgitation. Lancet Gastroenterol. Hepatol. 2020 5 6 519 521 10.1016/S2468‑1253(20)30002‑9 32178771
    [Google Scholar]
  3. Richter J.E. Rubenstein J.H. Presentation and epidemiology of gastroesophageal reflux disease. Gastroenterology 2018 154 2 267 276 10.1053/j.gastro.2017.07.045 28780072
    [Google Scholar]
  4. Maret-Ouda J. Markar S.R. Lagergren J. Gastroesophageal reflux disease. JAMA 2020 324 24 2536 2547 10.1001/jama.2020.21360 33351048
    [Google Scholar]
  5. Mittal R. Vaezi M.F. Esophageal motility disorders and gastroesophageal reflux disease. N. Engl. J. Med. 2020 383 20 1961 1972 10.1056/NEJMra2000328 33176086
    [Google Scholar]
  6. Peery A.F. Crockett S.D. Murphy C.C. Lund J.L. Dellon E.S. Williams J.L. Jensen E.T. Shaheen N.J. Barritt A.S. Lieber S.R. Kochar B. Barnes E.L. Fan Y.C. Pate V. Galanko J. Baron T.H. Sandler R.S. Burden and cost of gastrointestinal, liver, and pancreatic diseases in the United States: Update 2018. Gastroenterology 2019 156 1 254 272.e11 10.1053/j.gastro.2018.08.063 30315778
    [Google Scholar]
  7. Katz P.O. Dunbar K.B. Schnoll-Sussman F.H. Greer K.B. Yadlapati R. Spechler S.J. ACG clinical guideline for the diagnosis and management of gastroesophageal reflux disease. Am. J. Gastroenterol. 2022 117 1 27 56 10.14309/ajg.0000000000001538 34807007
    [Google Scholar]
  8. Gyawali C.P. Kahrilas P.J. Savarino E. Zerbib F. Mion F. Smout A.J.P.M. Vaezi M. Sifrim D. Fox M.R. Vela M.F. Tutuian R. Tack J. Bredenoord A.J. Pandolfino J. Roman S. Modern diagnosis of GERD: the Lyon Consensus. Gut 2018 67 7 1351 1362 10.1136/gutjnl‑2017‑314722 29437910
    [Google Scholar]
  9. Corley D.A. Kubo A. Body mass index and gastroesophageal reflux disease: A systematic review and meta-analysis. Am. J. Gastroenterol. 2006 101 11 2619 2628 10.1111/j.1572‑0241.2006.00849.x 16952280
    [Google Scholar]
  10. Hampel H. Abraham N.S. El-Serag H.B. Meta-analysis: Obesity and the risk for gastroesophageal reflux disease and its complications. Ann. Intern. Med. 2005 143 3 199 211 10.7326/0003‑4819‑143‑3‑200508020‑00006 16061918
    [Google Scholar]
  11. Ness-Jensen E. Lindam A. Lagergren J. Hveem K. Weight loss and reduction in gastroesophageal reflux. A prospective population-based cohort study: The HUNT study. Am. J. Gastroenterol. 2013 108 3 376 382 10.1038/ajg.2012.466 23358462
    [Google Scholar]
  12. Hsu C.S. Wang P.C. Chen J.H. Su W.C. Tseng T.C. Chen H.D. Hsiao T.H. Wang C.C. Lin H.H. Shyu R.Y. Chao Y.C. Increasing insulin resistance is associated with increased severity and prevalence of gastro-oesophageal reflux disease. Aliment. Pharmacol. Ther. 2011 34 8 994 1004 10.1111/j.1365‑2036.2011.04817.x 21848629
    [Google Scholar]
  13. Feinle-Bisset C. Azpiroz F. Dietary lipids and functional gastrointestinal disorders. Am. J. Gastroenterol. 2013 108 5 737 747 10.1038/ajg.2013.76 23567355
    [Google Scholar]
  14. Fox M. Barr C. Nolan S. Lomer M. Anggiansah A. Wong T. The effects of dietary fat and calorie density on esophageal acid exposure and reflux symptoms. Clin. Gastroenterol. Hepatol. 2007 5 4 439 444.e1 10.1016/j.cgh.2006.12.013 17363334
    [Google Scholar]
  15. El-Serag H.B. Satia J.A. Rabeneck L. Dietary intake and the risk of gastro-oesophageal reflux disease: A cross sectional study in volunteers. Gut 2005 54 1 11 17 10.1136/gut.2004.040337 15591498
    [Google Scholar]
  16. Schey R. Dickman R. Parthasarathy S. Quan S.F. Wendel C. Merchant J. Powers J. Han B. van Handel D. Fass R. Sleep deprivation is hyperalgesic in patients with gastroesophageal reflux disease. Gastroenterology 2007 133 6 1787 1795 10.1053/j.gastro.2007.09.039 18054551
    [Google Scholar]
  17. Oh J.H. Gastroesophageal reflux disease: Recent advances and its association with sleep. Ann. N. Y. Acad. Sci. 2016 1380 1 195 203 10.1111/nyas.13143 27391766
    [Google Scholar]
  18. Chakraborty T.K. Ogilvie A.L. Heading R.C. Ewing D.J. Abnormal cardiovascular reflexes in patients with gastro-oesophageal reflux. Gut 1989 30 1 46 49 10.1136/gut.30.1.46 2920926
    [Google Scholar]
  19. Caldwell M.T.P. Byrne P.J. Marks P. Walsh T.N. Hennessy T.P.J. Bradykinin, coronary artery disease and gastro-oesophageal reflux. Br. J. Surg. 1994 81 10 1462 1464 10.1002/bjs.1800811020 7820472
    [Google Scholar]
  20. Chen J. Sun Y. Fu T. Lu S. Shi W. Zhao J. Li S. Li X. Yuan S. Larsson S.C. Risk of incident cardiovascular disease among patients with gastrointestinal disorder: a prospective cohort study of 330 751 individuals. Eur. Heart J. Qual. Care Clin. Outcomes 2024 10 4 357 365 10.1093/ehjqcco/qcad059 37777843
    [Google Scholar]
  21. Hu Z. Chen M. Wu J. Song Q. Yan C. Du X. Wang Z. Improved control of hypertension following laparoscopic fundoplication for gastroesophageal reflux disease. Front. Med. 2017 11 1 68 73 10.1007/s11684‑016‑0490‑7 28213877
    [Google Scholar]
  22. Krakowska-Stasiak M. Cibor D. Grys I. Mach T. Owczarek D. Nonerosive reflux disease is more common in patients with chronic thyroid disease: preliminary results. Pol Arch Intern Med 2018 128 12 788 790 30516759
    [Google Scholar]
  23. Kessing B.F. Bredenoord A.J. Saleh C.M.G. Smout A.J.P.M. Effects of anxiety and depression in patients with gastroesophageal reflux disease. Clin. Gastroenterol. Hepatol. 2015 13 6 1089 1095.e1 10.1016/j.cgh.2014.11.034 25496817
    [Google Scholar]
  24. Taloyan M. Alinaghizadeh H. Wettermark B. Jan Hasselström J.H. Bertilson B.C. Physical-mental multimorbidity in a large primary health care population in Stockholm County, Sweden. Asian J. Psychiatr. 2023 79 103354 10.1016/j.ajp.2022.103354 36463815
    [Google Scholar]
  25. Davey Smith G. Hemani G. Mendelian randomization: Genetic anchors for causal inference in epidemiological studies. Hum. Mol. Genet. 2014 23 R1 R89 R98 10.1093/hmg/ddu328 25064373
    [Google Scholar]
  26. Burgess S. Butterworth A. Thompson S.G. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet. Epidemiol. 2013 37 7 658 665 10.1002/gepi.21758 24114802
    [Google Scholar]
  27. Pierce B.L. Burgess S. Efficient design for Mendelian randomization studies: Subsample and 2-sample instrumental variable estimators. Am. J. Epidemiol. 2013 178 7 1177 1184 10.1093/aje/kwt084 23863760
    [Google Scholar]
  28. Burgess S. Davey Smith G. Davies N.M. Dudbridge F. Gill D. Glymour M.M. Hartwig F.P. Kutalik Z. Holmes M.V. Minelli C. Morrison J.V. Pan W. Relton C.L. Theodoratou E. Guidelines for performing Mendelian randomization investigations: Update for summer 2023. Wellcome Open Res. 2019 4 186 10.12688/wellcomeopenres.15555.3 32760811
    [Google Scholar]
  29. Zamani M. Alizadeh-Tabari S. Chan W.W. Talley N.J. Association between anxiety/depression and gastroesophageal reflux: A systematic review and meta-analysis. Am. J. Gastroenterol. 2023 118 12 2133 2143 10.14309/ajg.0000000000002411 37463429
    [Google Scholar]
  30. Lian X. Lin Y. Peng X. Wang Y. He T. He Z. Gu W. Wang H. He F. Huang Y. Causal links between socioeconomic status, leisure sedentary behaviours and gastro-oesophageal reflux disease: a multivariable two-sample Mendelian randomisation study. J. Epidemiol. Community Health 2023 77 7 460 467 10.1136/jech‑2023‑220311 37185224
    [Google Scholar]
  31. Zhao X. Ding R. Su C. Yue R. Sleep traits, fat accumulation, and glycemic traits in relation to gastroesophageal reflux disease: A Mendelian randomization study. Front. Nutr. 2023 10 1106769 10.3389/fnut.2023.1106769 36895273
    [Google Scholar]
  32. Pe’er I. Yelensky R. Altshuler D. Daly M.J. Estimation of the multiple testing burden for genomewide association studies of nearly all common variants. Genet. Epidemiol. 2008 32 4 381 385 10.1002/gepi.20303 18348202
    [Google Scholar]
  33. Bowden J. Davey Smith G. Burgess S. Mendelian randomization with invalid instruments: Effect estimation and bias detection through Egger regression. Int. J. Epidemiol. 2015 44 2 512 525 10.1093/ije/dyv080 26050253
    [Google Scholar]
  34. Burgess S. Thompson S.G. Collaboration C.C.G. CRP CHD Genetics Collaboration Avoiding bias from weak instruments in Mendelian randomization studies. Int. J. Epidemiol. 2011 40 3 755 764 10.1093/ije/dyr036 21414999
    [Google Scholar]
  35. Shim H. Chasman D.I. Smith J.D. Mora S. Ridker P.M. Nickerson D.A. Krauss R.M. Stephens M. A multivariate genome-wide association analysis of 10 LDL subfractions, and their response to statin treatment, in 1868 Caucasians. PLoS One 2015 10 4 e0120758 10.1371/journal.pone.0120758 25898129
    [Google Scholar]
  36. Palmer T.M. Sterne J.A.C. Harbord R.M. Lawlor D.A. Sheehan N.A. Meng S. Granell R. Smith G.D. Didelez V. Instrumental variable estimation of causal risk ratios and causal odds ratios in Mendelian randomization analyses. Am. J. Epidemiol. 2011 173 12 1392 1403 10.1093/aje/kwr026 21555716
    [Google Scholar]
  37. Bowden J. Davey Smith G. Haycock P.C. Burgess S. Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator. Genet. Epidemiol. 2016 40 4 304 314 10.1002/gepi.21965 27061298
    [Google Scholar]
  38. Bowden J. Del Greco M F. Minelli C. Davey Smith G. Sheehan N. Thompson J. A framework for the investigation of pleiotropy in two-sample summary data Mendelian randomization. Stat. Med. 2017 36 11 1783 1802 10.1002/sim.7221 28114746
    [Google Scholar]
  39. Verbanck M. Chen C.Y. Neale B. Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat. Genet. 2018 50 5 693 698 10.1038/s41588‑018‑0099‑7 29686387
    [Google Scholar]
  40. Sanderson E. Multivariable mendelian randomization and mediation. Cold Spring Harb. Perspect. Med. 2021 11 2 a038984 10.1101/cshperspect.a038984 32341063
    [Google Scholar]
  41. Hemani G. Zheng J. Elsworth B. Wade K.H. Haberland V. Baird D. Laurin C. Burgess S. Bowden J. Langdon R. Tan V.Y. Yarmolinsky J. Shihab H.A. Timpson N.J. Evans D.M. Relton C. Martin R.M. Davey Smith G. Gaunt T.R. Haycock P.C. The MR-Base platform supports systematic causal inference across the human phenome. eLife 2018 7 e34408 10.7554/eLife.34408 29846171
    [Google Scholar]
  42. Eusebi L.H. Ratnakumaran R. Yuan Y. Solaymani-Dodaran M. Bazzoli F. Ford A.C. Global prevalence of, and risk factors for, gastro-oesophageal reflux symptoms: a meta-analysis. Gut 2018 67 3 430 440 10.1136/gutjnl‑2016‑313589 28232473
    [Google Scholar]
  43. Xie J. Huang H. Liu Z. Li Y. Yu C. Xu L. Xu C. The associations between modifiable risk factors and nonalcoholic fatty liver disease: A comprehensive Mendelian randomization study. Hepatology 2023 77 3 949 964 10.1002/hep.32728 35971878
    [Google Scholar]
  44. Green H.D. Beaumont R.N. Wood A.R. Hamilton B. Jones S.E. Goodhand J.R. Kennedy N.A. Ahmad T. Yaghootkar H. Weedon M.N. Frayling T.M. Tyrrell J. Genetic evidence that higher central adiposity causes gastro-oesophageal reflux disease: a Mendelian randomization study. Int. J. Epidemiol. 2020 49 4 1270 1281 10.1093/ije/dyaa082 32588049
    [Google Scholar]
  45. Singh S. Sharma A.N. Murad M.H. Buttar N.S. El-Serag H.B. Katzka D.A. Iyer P.G. Central adiposity is associated with increased risk of esophageal inflammation, metaplasia, and adenocarcinoma: a systematic review and meta-analysis. Clin. Gastroenterol. Hepatol. 2013 11 11 1399 1412.e7 10.1016/j.cgh.2013.05.009 23707461
    [Google Scholar]
  46. Stefan N. Causes, consequences, and treatment of metabolically unhealthy fat distribution. Lancet Diabetes Endocrinol. 2020 8 7 616 627 10.1016/S2213‑8587(20)30110‑8 32559477
    [Google Scholar]
  47. Magkos F. Fraterrigo G. Yoshino J. Luecking C. Kirbach K. Kelly S.C. de las Fuentes L. He S. Okunade A.L. Patterson B.W. Klein S. Effects of moderate and subsequent progressive weight loss on metabolic function and adipose tissue biology in humans with obesity. Cell Metab. 2016 23 4 591 601 10.1016/j.cmet.2016.02.005 26916363
    [Google Scholar]
  48. Cadiot G. Delaage P.H. Fabry C. Soufflet C. Barthélemy P. Sleep disturbances associated with gastro-oesophageal reflux disease: Prevalence and impact of treatment in French primary care patients. Dig. Liver Dis. 2011 43 10 784 787 10.1016/j.dld.2011.06.004 21752736
    [Google Scholar]
  49. Yang X.J. Jiang H.M. Hou X.H. Song J. Anxiety and depression in patients with gastroesophageal reflux disease and their effect on quality of life. World J. Gastroenterol. 2015 21 14 4302 4309 10.3748/wjg.v21.i14.4302 25892882
    [Google Scholar]
  50. Martin A.R. Kanai M. Kamatani Y. Okada Y. Neale B.M. Daly M.J. Clinical use of current polygenic risk scores may exacerbate health disparities. Nat. Genet. 2019 51 4 584 591 10.1038/s41588‑019‑0379‑x 30926966
    [Google Scholar]
  51. Thukkani N. Sonnenberg A. The influence of environmental risk factors in hospitalization for gastro-oesophageal reflux disease-related diagnoses in the United States. Aliment. Pharmacol. Ther. 2010 31 8 852 861 10.1111/j.1365‑2036.2010.04245.x 20102354
    [Google Scholar]
  52. Cook M.B. Wild C.P. Forman D. A systematic review and meta-analysis of the sex ratio for Barrett’s esophagus, erosive reflux disease, and nonerosive reflux disease. Am. J. Epidemiol. 2005 162 11 1050 1061 10.1093/aje/kwi325 16221805
    [Google Scholar]
/content/journals/cmc/10.2174/0109298673372983250710031732
Loading
Causal Relationships Between Modifiable Risk Factors and Gastroesophageal Reflux Disease: A Two-Sample Mendelian Randomization Study
Bentham Science Publishers ; https://doi.org/10.2174/0109298673372983250710031732
/content/journals/cmc/10.2174/0109298673372983250710031732
/content/journals/cmc/10.2174/0109298673372983250710031732
Loading

Data & Media loading...

Supplements

Supplementary material is available on the publisher’s website along with the published article.

file format download Download

  • Article Type:     Research Article
Keywords: mental health disorders ; MR ; gastroesophageal reflux disease ; peripheral adiposity ; Mendelian randomization ; GERD

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test